Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Keeps you up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
![Essential](https://www.g2intelligence.com/wp-content/uploads/2023/11/Essential.png)
![62934_G2_Subscription Website Images_JL V1](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V1.png)
![Special-Report](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Report.png)
![62934_G2_Subscription Website Images_JL V12](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V12.png)
![Special-Analysis](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Analysis.png)
![Elite](https://www.g2intelligence.com/wp-content/uploads/2023/11/Elite.png)
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
![paper_magnifing_glass_512](https://www.g2intelligence.com/wp-content/uploads/2023/11/paper_magnifing_glass_512.png)
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
Cigna Becomes First Insurer to Cover Whole Exome Sequencing
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Cigna became the first national health insurance plan to publish a coverage policy on whole exome sequencing (WES). The insurer defined coverage criteria for WES, but still will not cover WGS for...
Re-evaluate and Update Your Compliance Plans
From - G2 Compliance Advisor
The Department of Justice (DOJ) and the U.S. Department of Health and Human Services' Office of Inspector General (OIG) have been very active in fraud prevention and enforcement, recovering $3.3 billion in taxpayer dollars in…
Point-of-Care Tests Likely to Become Bigger Factor in Lab Business Moving Forward
From - Laboratory Industry Report
For decades, the mechanics of laboratory testing have been at a physical remove from the bulk of health care delivery. A blood draw or tissue sample is performed on a patient at one site and…
HHS’ Top Ten Management Problems Include Labs
By Kelly A. Briganti, Editorial Director, G2 Intelligence The OIG's FY 2015 Top Management and Performance Challenges target clinical laboratories among other providers as a necessary focus of efforts to fight fraud, abuse and waste in Medicare. Specifically, the...